Search research articles
Contact Us
Filters
Showing results (411-420 of 434) with videos related to
Page
of 44
Sort By:
The New England Journal of Medicine
|
November 19, 2004
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
Sandeep S Dave, George Wright, Bruce Tan, et al.
The New England Journal of Medicine
|
June 9, 2006
Molecular diagnosis of Burkitt's lymphoma
Sandeep S Dave, Kai Fu, George W Wright, et al.
Blood
|
May 3, 2024
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)
Laura K Hilton, Brett Collinge, Susana Ben-Neriah, et al.
Cancer Cell
|
June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypes
Julius C Enssle, Björn Häupl, Arber Qoku, et al.
Nature
|
June 22, 2018
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
James D Phelan, Ryan M Young, Daniel E Webster, et al.
The New England Journal of Medicine
|
April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
Roland Schmitz, George W Wright, Da Wei Huang, et al.
Nature
|
January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R Eric Davis, Vu N Ngo, Georg Lenz, et al.
Cancer Cell
|
March 7, 2003
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Andreas Rosenwald, George Wright, Adrian Wiestner, et al.
Blood Advances
|
July 17, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Brett J Collinge, Laura K Hilton, Jasper Chun Hei Wong, et al.
The New England Journal of Medicine
|
June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
Andreas Rosenwald, George Wright, Wing C Chan, et al.
Page
of 44
Search research articles
Search
Showing results (411-420 of 434) with videos related to
Sort By:
Page
of 44
The New England Journal of Medicine
|
November 19, 2004
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
Sandeep S Dave, George Wright, Bruce Tan, et al.
The New England Journal of Medicine
|
June 9, 2006
Molecular diagnosis of Burkitt's lymphoma
Sandeep S Dave, Kai Fu, George W Wright, et al.
Blood
|
May 3, 2024
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)
Laura K Hilton, Brett Collinge, Susana Ben-Neriah, et al.
Cancer Cell
|
June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypes
Julius C Enssle, Björn Häupl, Arber Qoku, et al.
Nature
|
June 22, 2018
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
James D Phelan, Ryan M Young, Daniel E Webster, et al.
The New England Journal of Medicine
|
April 12, 2018
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
Roland Schmitz, George W Wright, Da Wei Huang, et al.
Nature
|
January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R Eric Davis, Vu N Ngo, Georg Lenz, et al.
Cancer Cell
|
March 7, 2003
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Andreas Rosenwald, George Wright, Adrian Wiestner, et al.
Blood Advances
|
July 17, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Brett J Collinge, Laura K Hilton, Jasper Chun Hei Wong, et al.
The New England Journal of Medicine
|
June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
Andreas Rosenwald, George Wright, Wing C Chan, et al.
Page
of 44